- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Do | European Network Remembrance and Solidarity: International Holocaust Remembrance Day | 155 | education and information campaignWARSAW, Poland, Jan. 23, 2025 (GLOBE NEWSWIRE) -- On January 27, we observe International Holocaust Remembrance Day, marking the anniversary of the liberation of Auschwitz-Birkenau... ► Artikel lesen | ||
| Do | Nokia Oyj: Changes in Nokia Corporation's own shares | 283 | Nokia CorporationStock Exchange Release23 January 2025 at 16:00 EETChanges in Nokia Corporation's own shares
Espoo, Finland - A total of 39 963 Nokia shares (NOKIA) held by the company were transferred... ► Artikel lesen | ||
| Do | ROLI unveils the future of the piano at NAMM, with launch of flagship ROLI Piano and Piano AI Assistant | 230 | These innovative new products combine with ROLI Airwave to create a complete, intelligent system for music learning and creation.
LONDON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Hot on the heels... ► Artikel lesen | ||
| Do | PathAI inc: PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions | 218 | Collaboration Marks First At-Scale Deployment of AI Technologies into Leading Commercial BiobankBOSTON and HUNTSVILLE, Ala, Jan. 23, 2025, a leading biospecimens and specialty lab testing company, to... ► Artikel lesen | ||
| Do | Tiziana Life Sciences Ltd.: Tiziana Life Sciences not to engage in capital raising activities for the immediate future | 239 | NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its... ► Artikel lesen | ||
| Do | ZenaTech Inc.: ZenaTech Acquires KJM Land Surveying LLC, a Second Acquisition to Accelerate Drone Innovation in Land Surveys and Establish a Southeast Base for its Drone as a Service Business | 214 | VANCOUVER, British Columbia, Jan. 23, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone-as-a-Service... ► Artikel lesen | ||
| Do | Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome | 88 | Four Weeks After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured Endpoints ObservedData Supports QRX003 Mechanism of Action as a Competitive... ► Artikel lesen | ||
| Do | Haoxi Health Technology Limited Announces 1-for-25 Reverse Share Split | 76 | BEIJING, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced that it... ► Artikel lesen | ||
| Do | West Bancorporation, Inc. Announces Fourth Quarter and Year End 2024 Financial Results and Declares Quarterly Dividend | 103 | WEST DES MOINES, Iowa, Jan. 23, 2025 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (Nasdaq: WTBA; the "Company"), parent company of West Bank, today reported 2024 net income of $24.1 million, or $1.42... ► Artikel lesen | ||
| Do | Safety Shot, Inc.: Safety Shot Reaches an Amicable Litigation Settlement Agreement, Strengthening Financial Position and Fostering Strategic Partnerships | 66 | SCOTTSDALE, Ariz., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or the "Company"), a wellness and dietary supplement company, today announced that it has reached... ► Artikel lesen | ||
| Do | Skyline Builders Group Holding Limited Announces Pricing of Approximately $6 Million Initial Public Offering | 100 | Hong Kong, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Skyline Builders Group Holding Limited (NASDAQ: SKBL) (the "Company"), a civil engineering services provider in Hong Kong, today announced the pricing... ► Artikel lesen | ||
| Do | La Rosa Holdings Corp. Reports Unaudited Preliminary Revenue of Approximately $65 Million for Fiscal Year 2024, Achieving 104% Year-Over-Year Growth | 90 | Celebration, FL, Jan. 23, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa" or the "Company"), a holding company for six agent-centric, technology-integrated, cloud-based,... ► Artikel lesen | ||
| Do | Banzai International, Inc.: Banzai Announces Definitive Agreement to Acquire Act-On Software, Growing TTM Revenue 152% to $44M | 118 | SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales... ► Artikel lesen | ||
| Do | American Rare Earths Updates Shareholders | 118 | SYDNEY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- 2024 has been a transformative year for American Rare Earths (ARR), positioning us as a leader in reshaping the U.S. rare earths industry. The re-election... ► Artikel lesen | ||
| Do | Camurus AB: Camurus' fourth quarter and full year 2024 earnings above previous estimates | 93 | Lund, Sweden - 23 January 2025 - Camurus (NASDAQ STO: CAMX) today announced preliminary financial results for 2024:
Full year total revenues are expected at SEK 1,868 million, in the high end of... ► Artikel lesen | ||
| Do | Atossa Therapeutics, Inc.: Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025 | 143 | SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | ||
| Do | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia | 96 | - REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical... ► Artikel lesen | ||
| Do | Marimekko Corporation: Marimekko's emission reduction targets approved by the Science Based Targets initiative | 150 | Marimekko Corporation, Press Release, 23 January 2025 at 3.00 p.m. EET
Marimekko's emission reduction targets approved by the Science Based Targets initiative
The Science Based Target initiative... ► Artikel lesen | ||
| Do | Salsify: New Survey - 69% of Shoppers Buy While Multitasking-Is Retail Ready for the Always-On Consumer? | 201 | AI tools, viral trends, and live shopping are fueling seismic shifts in consumer behavior, according to Salsify's 2025 Consumer Research ReportBOSTON, Jan. 23, 2025, the platform empowering brand manufacturers... ► Artikel lesen | ||
| Do | Lisata Therapeutics, Inc.: Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma | 97 | Data corroborate previously reported preclinical data demonstrating certepetide's ability to enhance the effectiveness of immunotherapy Preliminary results to be presented at the 2025 ASCO Gastrointestinal... ► Artikel lesen | ||
| Do | First Mid Bancshares, Inc. Announces Fourth Quarter 2024 Results | 604 | MATTOON, Ill., Jan. 23, 2025 (GLOBE NEWSWIRE) -- First Mid Bancshares, Inc. (NASDAQ: FMBH) (the "Company") today announced its financial results for the quarter ended December 31, 2024. Highlights... ► Artikel lesen | ||
| Do | Conduit Pharmaceuticals Inc. Announces Reverse Stock Split | 96 | NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit" or the "Company"), a multi-asset, clinical stage, disease-agnostic... ► Artikel lesen | ||
| Do | Oryzon Genomics, S.A.: ORYZON announces first patient dosed in an Investigator-initiated Phase I study of iadademstat in myelodysplastic syndrome | 356 | Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015... ► Artikel lesen | ||
| Do | Liveone, Inc.: LiveOne's (Nasdaq: LVO) Tesla Partnership Surpasses Projections with Over 600,000 Users, 33% Increase Since Jan. 1st | 71 | - New Users Include 275K+ Ad-Supported - Signed $40+M in B2B Partnerships last 60 Days - B2B Pipeline Expands to Over 70 Companies - Utilizing AI and Data Mining to Monetize Database LOS ANGELES,... ► Artikel lesen | ||
| Do | ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer | 100 | Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor response and a well-tolerated safety profile in a... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
